Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 11.1B | 9.6B | 8.2B | 7.3B |
| Cost of revenue | 5.1B | 3.9B | 3.7B | 2.9B |
| Gross profit | 6.0B | 5.8B | 4.5B | 4.4B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 283.9M | 1.1B | 190.6M | 193.1M |
| Operating income | 4.7B | 3.7B | 3.7B | 3.5B |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 25.7M | — | — | — |
| Pretax income | 3.8B | 3.2B | 2.7B | 2.8B |
| Tax provision | 908.6M | 1.0B | 677.5M | 594.9M |
| Net income | 2.9B | 2.2B | 2.0B | 2.3B |
| Basic EPS | 5.7 | 4.3 | 3.9 | 4.5 |
| Diluted EPS | 5.7 | 4.3 | 3.9 | 4.5 |
| Basic average shares | 505.3M | 505.3M | 505.3M | 505.3M |
| Diluted average shares | 505.3M | 505.3M | 505.3M | 505.3M |
| EBITDA | 5.6B | 5.8B | 4.5B | 4.2B |
| Net income from continuing op. | 2.9B | 2.2B | 2.0B | 2.3B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |